Regulation of monocyte subset proinflammatory responses within the lung microvasculature by the p38 MAPK/MK2 pathway

Abstract

Margination and activation of monocytes within the pulmonary microcirculation contribute substantially to the development of acute lung injury in mice. The enhanced LPS-induced TNF expression exhibited by Gr-1high compared with Gr-1low monocytes within the lung microvasculature suggests differential roles for these subsets. We investigated the mechanisms responsible for such heterogeneity of lung-marginated monocyte proinflammatory response using a combined in vitro and in vivo approach. The monocyte subset inflammatory response was studied in vitro in mouse peripheral blood mononuclear cell-lung endothelial cell coculture and in vivo in a two-hit model of intravenous LPS-induced monocyte margination and lung inflammation in mice, by flow cytometry-based quantification of proinflammatory genes and intracellular phospho-kinases. With LPS stimulation in vitro, TNF expression was consistently higher in Gr-1high than Gr-1low monocytes, markedly enhanced by coculture with endothelial cells, and abrogated by p38 MAPK inhibitors. Expression of IL-6, inducible nitric oxide synthase (iNOS), and cyclooxygenase-2 (COX-2) was only detectable under coculture conditions, was substantially higher in Gr-1high monocytes, and was attenuated by p38 inhibition. Consistent with these differential responses, phosphorylation of p38 and its substrate MAPK-activated protein kinase 2 (MK2) was significantly higher in the Gr-1high subset. In vivo, p38 inhibitor treatment significantly attenuated LPS-induced TNF expression in “lung-marginated” Gr-1high monocytes. LPS-induced p38/MK2 phosphorylation was higher in lung-marginated Gr-1high than Gr-1low monocytes and neutrophils, mirroring TNF expression. These results indicate that the p38/MK2 pathway is a critical determinant of elevated Gr-1high subset responsiveness within the lung microvasculature, producing a coordinated proinflammatory response that places Gr-1high monocytes as key orchestrators of pulmonary microvascular inflammation and injury.

Excess Soluble CD40L Contributes to Blood Brain Barrier Permeability In Vivo: Implications for HIV-Associated Neurocognitive Disorders

“…Twenty-four hours post treatment, cortical windows were created and time-lapse videos were captured at depths up to approximately 200 microns. Leukocytes (monocytes, neutrophils) were labeled using fluorescently conjugated antibody directed against granulocyte antigen 1 (Gr1; aka Ly-6C/G), as murine monocytes expressing high levels of Gr1 have been shown to be representative of the “inflammatory” monocyte population that corresponds to the CD16 high monocyte subset within humans [48]–[50], and the Gr1 antigen is also representative of a widely used panel of markers for activated monocytes in mice [51]–[53]. These mice were also exposed to Texas Red Dextran for the illumination of vessels.…”

PEDF expression regulates the proangiogenic and proinflammatory phenotype of the lung endothelium

“…Others have shown that exposure of mice to LPS results in inflammation and increased expression of VEGF in the lung (20). Furthermore, VCAM-1 expression is increased in LPStreated mouse lung EC compared with nontreated cells (28). Thus PEDF deficiency in the lung endothelium may promote the progression of inflammation.…”

The response of the innate immune and cardiovascular systems to LPS in pregnant and nonpregnant mice†

“…Cell suspension and whole blood were incubated with the following fluorophore-conjugated rat anti-mouse mAbs antibodies used: Ly6C (HK1.4) (BioLegend), Gr1 (RB6-8C5) (BioLegend), NK1. [29]. In lung tissue, Ly6C lo subset monocytes were distinguished from interstitial macrophages by low expression of MHC II (Supplementary Figure S1) [30].…”